The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
300 jobs Number of planned job creations
Announcement Date
10 June 2026
Employment effect (start)
10 June 2026
Foreseen end date
31 December 2026
Description
ELPEN, a Greek pharmaceutical company operating in pharmaceutical manufacturing, is creating 300 jobs at its new production facility in Keratea, East Attica. According to ELPEN’s current facilities information, New Plant I in Keratea covers 15,000 square metres, employs 300 people and manufactures inhalation products, tablets and capsules, with annual full-capacity output of 71 million packages.
ELPEN’s wider investment programme also foresees additional job creation through the expansion of its Pikermi facilities, a second Keratea plant planned for 2026–2027, a distribution centre in Markopoulo and a new oncology drugs plant in Tripoli with Win Medica.
Citation
Eurofound (2026), ELPEN, Business expansion in Greece, factsheet number 300623, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/300623.